Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels

Implications in disease mechanism and sulfonylurea therapy

Chia Wei Lin, Yu Wen Lin, Fei Fei Yan, Jillene Casey, Malini Kochhar, Emily B. Pratt, Show-Ling Shyng

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Heterozygous missense mutations in the pore-forming subunit Kir6.2 of ATP-sensitive K+ channels (KATP channels) have recently been shown to cause permanent neonatal diabetes mellitus (PNDM). Functional studies demonstrated that PNDM mutations reduce KATP channel sensitivity to ATP inhibition, resulting in gain of channel function. However, the impact of these mutations on channel expression has not been examined. Here, we show that PNDM mutations, including Q52R, V59G, V59M, R201C, R201H, and I296L, not only reduce channel ATP sensitivity but also impair channel expression at the cell surface to varying degrees. By tagging the PNDM Kir6.2 mutant V59G or R201H with an additional mutation, N160D, that confers voltage-dependent polyamine block of KATP channels, we demonstrate that in simulated heterozygous state, all surface channels are either wild-type or heteromeric channels containing both wild-type and mutant Kir6.2 subunits. Comparison of the various PNDM mutations in their effects on channel nucleotide sensitivity and expression, as well as disease phenotype, suggests that both channel-gating defect and expression level may play a role in determining disease severity. Interestingly, sulfonylureas significantly increase surface expression of certain PNDM mutants, suggesting that the efficacy of sulfonylurea therapy may be compromised by the effect of these drugs on channel expression.

Original languageEnglish (US)
Pages (from-to)1738-1746
Number of pages9
JournalDiabetes
Volume55
Issue number6
DOIs
StatePublished - 2006

Fingerprint

Adenosine Triphosphate
Mutation
Therapeutics
Polyamines
Missense Mutation
Permanent Neonatal Diabetes Mellitus
Nucleotides
Phenotype
Pharmaceutical Preparations

Keywords

  • CHOP, CIEBP homolog protein
  • DEND, developmental delay, epilepsy, and neonatal diabetes
  • K channel, ATP-sensitive K channel
  • PNDM, permanent neonatal diabetes mellitus
  • SUR1, sulfonylurea receptor one

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels : Implications in disease mechanism and sulfonylurea therapy. / Lin, Chia Wei; Lin, Yu Wen; Yan, Fei Fei; Casey, Jillene; Kochhar, Malini; Pratt, Emily B.; Shyng, Show-Ling.

In: Diabetes, Vol. 55, No. 6, 2006, p. 1738-1746.

Research output: Contribution to journalArticle

Lin, Chia Wei ; Lin, Yu Wen ; Yan, Fei Fei ; Casey, Jillene ; Kochhar, Malini ; Pratt, Emily B. ; Shyng, Show-Ling. / Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels : Implications in disease mechanism and sulfonylurea therapy. In: Diabetes. 2006 ; Vol. 55, No. 6. pp. 1738-1746.
@article{8b73df09d3f24032bce5ea75a72cc617,
title = "Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels: Implications in disease mechanism and sulfonylurea therapy",
abstract = "Heterozygous missense mutations in the pore-forming subunit Kir6.2 of ATP-sensitive K+ channels (KATP channels) have recently been shown to cause permanent neonatal diabetes mellitus (PNDM). Functional studies demonstrated that PNDM mutations reduce KATP channel sensitivity to ATP inhibition, resulting in gain of channel function. However, the impact of these mutations on channel expression has not been examined. Here, we show that PNDM mutations, including Q52R, V59G, V59M, R201C, R201H, and I296L, not only reduce channel ATP sensitivity but also impair channel expression at the cell surface to varying degrees. By tagging the PNDM Kir6.2 mutant V59G or R201H with an additional mutation, N160D, that confers voltage-dependent polyamine block of KATP channels, we demonstrate that in simulated heterozygous state, all surface channels are either wild-type or heteromeric channels containing both wild-type and mutant Kir6.2 subunits. Comparison of the various PNDM mutations in their effects on channel nucleotide sensitivity and expression, as well as disease phenotype, suggests that both channel-gating defect and expression level may play a role in determining disease severity. Interestingly, sulfonylureas significantly increase surface expression of certain PNDM mutants, suggesting that the efficacy of sulfonylurea therapy may be compromised by the effect of these drugs on channel expression.",
keywords = "CHOP, CIEBP homolog protein, DEND, developmental delay, epilepsy, and neonatal diabetes, K channel, ATP-sensitive K channel, PNDM, permanent neonatal diabetes mellitus, SUR1, sulfonylurea receptor one",
author = "Lin, {Chia Wei} and Lin, {Yu Wen} and Yan, {Fei Fei} and Jillene Casey and Malini Kochhar and Pratt, {Emily B.} and Show-Ling Shyng",
year = "2006",
doi = "10.2337/db05-1571",
language = "English (US)",
volume = "55",
pages = "1738--1746",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels

T2 - Implications in disease mechanism and sulfonylurea therapy

AU - Lin, Chia Wei

AU - Lin, Yu Wen

AU - Yan, Fei Fei

AU - Casey, Jillene

AU - Kochhar, Malini

AU - Pratt, Emily B.

AU - Shyng, Show-Ling

PY - 2006

Y1 - 2006

N2 - Heterozygous missense mutations in the pore-forming subunit Kir6.2 of ATP-sensitive K+ channels (KATP channels) have recently been shown to cause permanent neonatal diabetes mellitus (PNDM). Functional studies demonstrated that PNDM mutations reduce KATP channel sensitivity to ATP inhibition, resulting in gain of channel function. However, the impact of these mutations on channel expression has not been examined. Here, we show that PNDM mutations, including Q52R, V59G, V59M, R201C, R201H, and I296L, not only reduce channel ATP sensitivity but also impair channel expression at the cell surface to varying degrees. By tagging the PNDM Kir6.2 mutant V59G or R201H with an additional mutation, N160D, that confers voltage-dependent polyamine block of KATP channels, we demonstrate that in simulated heterozygous state, all surface channels are either wild-type or heteromeric channels containing both wild-type and mutant Kir6.2 subunits. Comparison of the various PNDM mutations in their effects on channel nucleotide sensitivity and expression, as well as disease phenotype, suggests that both channel-gating defect and expression level may play a role in determining disease severity. Interestingly, sulfonylureas significantly increase surface expression of certain PNDM mutants, suggesting that the efficacy of sulfonylurea therapy may be compromised by the effect of these drugs on channel expression.

AB - Heterozygous missense mutations in the pore-forming subunit Kir6.2 of ATP-sensitive K+ channels (KATP channels) have recently been shown to cause permanent neonatal diabetes mellitus (PNDM). Functional studies demonstrated that PNDM mutations reduce KATP channel sensitivity to ATP inhibition, resulting in gain of channel function. However, the impact of these mutations on channel expression has not been examined. Here, we show that PNDM mutations, including Q52R, V59G, V59M, R201C, R201H, and I296L, not only reduce channel ATP sensitivity but also impair channel expression at the cell surface to varying degrees. By tagging the PNDM Kir6.2 mutant V59G or R201H with an additional mutation, N160D, that confers voltage-dependent polyamine block of KATP channels, we demonstrate that in simulated heterozygous state, all surface channels are either wild-type or heteromeric channels containing both wild-type and mutant Kir6.2 subunits. Comparison of the various PNDM mutations in their effects on channel nucleotide sensitivity and expression, as well as disease phenotype, suggests that both channel-gating defect and expression level may play a role in determining disease severity. Interestingly, sulfonylureas significantly increase surface expression of certain PNDM mutants, suggesting that the efficacy of sulfonylurea therapy may be compromised by the effect of these drugs on channel expression.

KW - CHOP, CIEBP homolog protein

KW - DEND, developmental delay, epilepsy, and neonatal diabetes

KW - K channel, ATP-sensitive K channel

KW - PNDM, permanent neonatal diabetes mellitus

KW - SUR1, sulfonylurea receptor one

UR - http://www.scopus.com/inward/record.url?scp=33748325742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748325742&partnerID=8YFLogxK

U2 - 10.2337/db05-1571

DO - 10.2337/db05-1571

M3 - Article

VL - 55

SP - 1738

EP - 1746

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -